SCHEMBL10195462

SCHEMBL10195462

CCc1ccc(Oc2nc3ccc(OC)cc3s2)cc1C1=C(O)CC2(CCOCC2)CC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 1/20 0.39
WNT3A P56704 1/20 0.35
ATAD2 Q6PL18 1/20 0.35
APP P05067 1/20 0.35
ALK Q9UM73 2/20 0.35
LRRK2 Q5S007 1/20 0.35
RAB9A P51151 5/20 0.34
SCD O00767 1/20 0.34
GAA P10253 1/20 0.34
NPC1 O15118 4/20 0.34
TSHR P16473 2/20 0.34
LTA4H P09960 1/20 0.34
TP53 P04637 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195516 0.91 LTA4H (0.34) SMN1; SMN2ALDH1A1MAPTKMT2AKDM4E
SCHEMBL13286529 0.91 MAPT (0.34) SMN1; SMN2ALDH1A1MAPTKMT2AKDM4E
SCHEMBL10195515 0.90 LTA4H (0.44) SMN1; SMN2LTA4H
SCHEMBL10195463 0.88 KMT2A (0.37) SMN1; SMN2ALDH1A1MAPTKMT2AKDM4E
SCHEMBL10195509 0.87 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1MAPTKMT2AKDM4E
SCHEMBL10195521 0.86 LTA4H (0.34) LTA4H
SCHEMBL10196229 0.83 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MAPTKMT2AKDM4E
SCHEMBL16351649 0.78 LPAR1 (0.35) SMN1; SMN2ALDH1A1KDM4EGAATSHR
SCHEMBL10195491 0.77 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1MAPTKMT2AKDM4E
SCHEMBL10195122 0.77 MAOB (0.37) SMN1; SMN2ALDH1A1KDM4ERAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 SMN1; SMN2 2218/4885ALDH1A1 45/4885MAPT 3785/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 SMN1; SMN2 2952/4885ALDH1A1 14/4885MAPT 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.